Kieger Healthcare Chart of the Month - Kieger
icon-menu-open Created with Sketch.
icon-menu-close Created with Sketch.
Kieger
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
News
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
Kieger Healthcare Chart of the Month

Kieger Healthcare Chart of the Month

With the human tragedy ongoing in Ukraine, much in this video will sound extremely secondary in nature and we wish nothing more than the war to end soon!

Fear and uncertainties are dominating the financial markets and in such a setting, investors are looking to protect their assets. Hi, it’s me again, Flavio from Kieger.

Healthcare, is a sector that is typically considered a defensive area of the market. Why is that? Well, patients continue to need their medications and therapies, no matter what happens. Thus, Healthcare revenue growth has one of the lowest correlations to global GDP growth. Healthcare over the past decades was able to outperform global equities as our chart of the month shows. The chart shows the Maximum Drawdown of the MSCI World and compares the MSCI Healthcare performance over the same time period.

At the beginning of the new millennial, as the dot-com bubble burst, Healthcare outperformed global equities by 36%. Years later, during the global financial crisis, Healthcare was 20% better than global equities. More recently, during Covid Healthcare outpaced global equities by 7%. Today, during the invasion of Ukraine, Healthcare was 3% better than global equities. While healthcare is outperforming on a relative basis, the sector is not immune against downturns. But for us as investors, this opens up great opportunities to buy high quality growth stocks which otherwise would have been too expensive.

Thank you for watching and once again, let us hope that this war will end soon.

Related News

Healthcare
7. June 2023

ASCO – American Society of Clinical Oncology Conference

We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.

Healthcare
1. June 2023

Kieger Healthcare Monthly Commentary

What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.

Healthcare
25. May 2023

Kieger Healthcare Chart of the Month

With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.

Contact

icon-menu-close Created with Sketch.

Get in contact with us by using the form below or via telephone. We look forward to hearing from you.

Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something went wrong. Try again later.

Thank you!

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem.

Kieger jobs

icon-menu-close Created with Sketch.

There are no job vacancies at the moment.